Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report

Int J Pharm Compd
August 2018
https://pubmed.ncbi.nlm.nih.gov/30021181/

Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy

Int Immunopharmacol
August 2018
https://pubmed.ncbi.nlm.nih.gov/29885638/

Low Dose Naltrexone and Lung Cancer: A Case Report and Discussion

Cureus
10 July 2018
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126779/

Low-dose naltrexone: A possible safe effective treatment for autoimmune disease and cancer

Anti-Aging Therapeutics, Volume 12, Chapter 3
January 2009
https://books.google.co.il/books?id=BSfzEE0tT9cC&lpg=PR7&dq=low%20dose%20naltrexone&pg=PR7#v=onepage&q=low%20dose%20naltrexone&f=false

The Long Term Suppression of Experimental Autoimmune Encephalomyelitis by the Opioid Growth Factor and Low Dose Naltrexone

The FASEB Journal
01 April 2011
https://doi.org/10.1096/fasebj.25.1_supplement.677.6 

Intermittent blockade of OGFr and treatment of autoimmune disorders

Exp Biol Med (Maywood)
December 2018
https://pubmed.ncbi.nlm.nih.gov/30541348/

Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study

PLoS One
14 February 2019
https://pubmed.ncbi.nlm.nih.gov/30763385/

Sjogren's Syndrome: Clinical Benefits of Low-dose Naltrexone Therapy

Cureus
11 March 2019
https://pubmed.ncbi.nlm.nih.gov/31123647/

Microglial Phagocytosis of Neurons: Diminishing Neuronal Loss in Traumatic, Infectious, Inflammatory, and Autoimmune CNS Disorders

Front Psychiatr
03 October 2019
https://www.frontiersin.org/articles/10.3389/fpsyt.2019.00712/full

Kris takes LDN for Chronic Lyme pain (Low-dose Naltrexone) from LDN Research Trust on Vimeo.